News

13
May

COVID-19 and clinical trials : point of view of Julie Autmizguine

COVID-19 and clinical trials : point of view of Julie Autmizguine In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Julie Autmizguine, Assistant Director of Clinical Research, Sainte-Justine UHC

Read more

11
May

COVID-19 and clinical trials : point of view of Luc Feldmann

COVID-19 and clinical trials : point of view of Luc Feldmann In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Luc Feldmann, Director, International Centre of Therapeutic Research, Servier Canada.

Read more

7
May

COVID-19 and clinical trials : point of view of Angela Genge

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Angela Genge, Neurologist and Director, Clinical Research Unit, Montreal Neurological Institute-Hospital.

21
Apr

COVID-19 and clinical trials : point of view of Dr. Gerald Batist

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders
in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following
statements detail the point of view of Dr. Gerald Batist, Deputy Director and Senior Investigator, Jewish
General Hospital’s Lady Davis Institute.

20
Apr

COVID-19 and clinical trials : point of view of Vatche Bartekian

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Vatche Bartekian, President of Vantage BioTrials Inc.

15
Apr

COVID-19 and clinical trials : point of view of Marc Rivière 

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Marc Rivière, Chief Medical Officer, TVM Capital and Chairman of the Board of Directors, CATALIS Québec. 

11
Mar

CATALIS Québec applauds the Quebec Government’s commitment to clinical research

The Quebec Government’s 2020–2021 budget, tabled yesterday by Minister of Finance Éric Girard, mentions investments in the field of clinical research, a commitment that was favourably received by CATALIS Québec’s board of directors.

24
Feb

CATALIS Québec Partners with The Coolest Hotspot Initiative

Quebec is a top destination for life sciences and clinical research. To strengthen our efforts to spread this message beyond Quebec, CATALIS Québec has joined The Coolest Hotspot network.

10
Feb

A clinical trial to improve pancreatic cancer treatment

A team from the CHU de Québec-Université Laval has begun a clinical trial in order to develop new therapeutic options for the treatment of pancreatic adenocarcinoma, an aggressive cancer whose survival rate is less than one year.

3
Feb

Solutions to Stimulate Clinical Research in Quebec

2020 promises to be a pivotal year for the rise of clinical research in Quebec. With our partners and sector stakeholders, we are taking concrete steps towards making Quebec an authority in the clinical trial sector.